This is the authors' abstract. We don't add key points for this paper.
Both acamprosate and oral naltrexone were associated with reduction in return to drinking. When directly compared with one another, no significant differences were found between acamprosate and naltrexone for controlling alcohol consumption. Factors such as dosing frequency, potential adverse events, and availability of treatments may guide medication choice.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jonas et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: